List of Excipients in API SUCCIMER
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing SUCCIMER
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Recordati Rare Diseases Inc | CHEMET | succimer | 55292-201 | FERRIC OXIDE RED | |
| Recordati Rare Diseases Inc | CHEMET | succimer | 55292-201 | GELATIN | |
| Recordati Rare Diseases Inc | CHEMET | succimer | 55292-201 | POVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for SUCCIMER
Excipient focus: ASCORBIC ACID
SUCCIMER drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
SUCCIMER drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
SUCCIMER drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
SUCCIMER drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
SUCCIMER drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
SUCCIMER drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
SUCCIMER drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: STANNOUS CHLORIDE
SUCCIMER drug variants containing STANNOUS CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing STANNOUS CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
SUCCIMER drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
SUCCIMER drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
SUCCIMER drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Recordati Rare Diseases Inc | succimer | 55292-201 |
| >Company | >Ingredient | >NDC |
SUCCIMER drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Theragnostics Inc | succimer | 71083-0020 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
